Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease

  1. Martín-Gutiérrez, N.
  2. Sánchez-Hernández, J.G.
  3. Rebollo, N.
  4. Pordomingo, A.F.
  5. Muñoz, F.
  6. Otero, M.J.
Journal:
European Journal of Hospital Pharmacy

ISSN: 2047-9964,  2047-9956

Year of publication: 2022

Volume: 29

Issue: 4

Pages: 222-227

Type: Article

DOI: 10.1136/EJHPHARM-2020-002410 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus